<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:media="http://search.yahoo.com/mrss/" >

<channel>
	<title>New Jersey 101.5 &#187; canagliflozin</title>
	<atom:link href="http://nj1015.com/tags/canagliflozin/feed/" rel="self" type="application/rss+xml" />
	<link>http://nj1015.com</link>
	<description>New Jersey News</description>
	<lastBuildDate>Tue, 21 May 2013 19:36:23 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>FDA Panel Backs Novel J&amp;J Diabetes Pill</title>
		<link>http://nj1015.com/fda-panel-backs-novel-jj-diabetes-pill/</link>
		<comments>http://nj1015.com/fda-panel-backs-novel-jj-diabetes-pill/#comments</comments>
		<pubDate>Thu, 10 Jan 2013 22:30:49 +0000</pubDate>
		<dc:creator>Townsquare News Network</dc:creator>
				<category><![CDATA[Townsquare News Network]]></category>
		<category><![CDATA[canagliflozin]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[national]]></category>
		<category><![CDATA[NJ]]></category>
		<category><![CDATA[njsyndicated]]></category>

		<guid isPermaLink="false">http://nj1015.com/?p=215131</guid>
		<description><![CDATA[A panel of federal health experts has ruled that an experimental diabetes drug from Johnson &#38; Johnson is safe and effective, though lingering safety questions must be tracked in long-term studies. The Food and Drug Administration&#8217;s panel of diabetes experts voted 10-5 in favor of J&#38;J&#8217;s canagliflozin to treat type 2 diabetes. The drug is [...]]]></description>
			<content:encoded><![CDATA[<p>A panel of federal health experts has ruled that an experimental diabetes drug from Johnson &amp; Johnson is safe and effective, though lingering safety questions must be tracked in long-term studies.
<p class="more_act text"><a href="http://nj1015.com/fda-panel-backs-novel-jj-diabetes-pill/" title="FDA Panel Backs Novel J&#038;J Diabetes Pill">Read More</a><em>|</em><a href="http://nj1015.com/fda-panel-backs-novel-jj-diabetes-pill/#comments_wrap" title="FDA Panel Backs Novel J&#038;J Diabetes Pill">Comment</a></p>
]]></content:encoded>
			<wfw:commentRss>http://nj1015.com/fda-panel-backs-novel-jj-diabetes-pill/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	<media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://wac.450F.edgecastcdn.net/80450F/nj1015.com/files/2013/01/JohnsonJohnson-300x1681.jpg" height="168" width="300" />	</item>
		<item>
		<title>Does Johnson &amp; Johnson Diabetes Drug Pose Heart Risk?</title>
		<link>http://nj1015.com/does-johnson-johnson-diabetes-drug-pose-heart-risk/</link>
		<comments>http://nj1015.com/does-johnson-johnson-diabetes-drug-pose-heart-risk/#comments</comments>
		<pubDate>Tue, 08 Jan 2013 23:15:04 +0000</pubDate>
		<dc:creator>Townsquare News Network</dc:creator>
				<category><![CDATA[Townsquare News Network]]></category>
		<category><![CDATA[canagliflozin]]></category>
		<category><![CDATA[diabetes]]></category>
		<category><![CDATA[heart health]]></category>
		<category><![CDATA[Johnson & Johnson]]></category>
		<category><![CDATA[national]]></category>
		<category><![CDATA[NJ]]></category>
		<category><![CDATA[njsyndicated]]></category>

		<guid isPermaLink="false">http://nj1015.com/?p=213997</guid>
		<description><![CDATA[Federal drug reviewers think Johnson &#38; Johnson&#8217;s experimental diabetes drug might bring heart risks because it raised cholesterol levels in patient testing. In documents just released, Food and Drug Administration staff experts conclude studies showed canagliflozin slightly increased heart complications and risk of a urinary tract infection. That&#8217;s because the pill works by boosting blood [...]]]></description>
			<content:encoded><![CDATA[<p>Federal drug reviewers think Johnson &amp; Johnson's experimental diabetes drug might bring heart risks because it raised cholesterol levels in patient testing.
<p class="more_act text"><a href="http://nj1015.com/does-johnson-johnson-diabetes-drug-pose-heart-risk/" title="Does Johnson &#038; Johnson Diabetes Drug Pose Heart Risk?">Read More</a><em>|</em><a href="http://nj1015.com/does-johnson-johnson-diabetes-drug-pose-heart-risk/#comments_wrap" title="Does Johnson &#038; Johnson Diabetes Drug Pose Heart Risk?">Comment</a></p>
]]></content:encoded>
			<wfw:commentRss>http://nj1015.com/does-johnson-johnson-diabetes-drug-pose-heart-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	<media:thumbnail xmlns:media="http://search.yahoo.com/mrss/" url="http://wac.450F.edgecastcdn.net/80450F/nj1015.com/files/2013/01/JohnsonJohnson-300x168.jpg" height="168" width="300" />	</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Page Caching using memcached
Object Caching 747/792 objects using memcached
Content Delivery Network via wac.450F.edgecastcdn.net/80450F/nj1015.com

Served from: nj1015.com @ 2013-05-21 19:49:32 -->